| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Dec 02, 2024 | Sale | $14.11 | 3,717 | 52,461 | 5,693 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Dec 04, 2024 | Option Exercise | $1.50 | 6,283 | 9,425 | 11,976 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Dec 04, 2024 | Sale | $14.00 | 6,283 | 87,962 | 5,693 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Dec 02, 2024 | Option Exercise | $1.50 | 3,717 | 5,576 | 9,410 | Dec 04, 2024, 09:40 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Sep 18, 2024 | Option Exercise | $1.50 | 10,000 | 15,000 | 15,693 | Sep 19, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Sep 18, 2024 | Sale | $14.00 | 10,000 | 140,000 | 5,693 | Sep 19, 2024, 04:30 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Aug 19, 2024 | Option Exercise | $1.50 | 10,000 | 15,000 | 15,693 | Aug 21, 2024, 06:51 PM | |
| SPRY | ARS Pharmaceuticals, Inc. | Karas Eric | Chief Commercial Officer | Aug 19, 2024 | Sale | $14.00 | 10,000 | 140,000 | 5,693 | Aug 21, 2024, 06:51 PM |
Menu